# Non-steroidal Anti-inflammatory Drug-Induced Severe Eosinophilia and Hematogone Hyperplasia Masquerading as Leukemia: Diagnostic Complexity in a Young Child

**Authors:** Shruti Saxena, Savitri Singh, Nita Radhakrishnan

PMC · DOI: 10.7759/cureus.99379 · Cureus · 2025-12-16

## TL;DR

A young child's severe eosinophilia and anemia after taking a non-steroidal anti-inflammatory drug were initially mistaken for leukemia but were later found to be drug-induced.

## Contribution

This case is the first to describe the coexistence of drug-induced eosinophilia and hematogone hyperplasia in a pediatric patient.

## Key findings

- Severe eosinophilia and anemia in a child were linked to a non-steroidal anti-inflammatory drug.
- Bone marrow analysis ruled out leukemia and confirmed reactive eosinophilia with hematogone hyperplasia.
- The case highlights the need for careful evaluation to avoid misdiagnosis in similar clinical scenarios.

## Abstract

Eosinophilia in pediatric patients may arise from a wide spectrum of underlying etiologies encompassing reactive, clonal, and idiopathic disorders. While reactive eosinophilia is common in childhood and typically related to infections, allergic or atopic disease, hypersensitivity reactions, or systemic inflammatory disorders, clonal eosinophilia is uncommon and may be associated with primary hematological malignancies. The distinction between reactive and clonal eosinophilia is clinically crucial, particularly in the presence of alarming features such as extreme leukocytosis, organomegaly, cytopenias, or circulating blasts that may mimic acute leukemia. We present the case of a three-year-old boy with severe eosinophilia and anemia following a short febrile illness and exposure to a non-steroidal anti-inflammatory drug combination, raising an initial suspicion of leukemia. Bone marrow examination and flow cytometry revealed significant hematogone hyperplasia with no evidence of acute leukemia, supporting a diagnosis of drug-induced reactive eosinophilia. The coexistence of hematogone hyperplasia and eosinophilia in this clinical setting has not been previously described. This case emphasizes the importance of systematic evaluation to avoid misdiagnosis and unnecessary evaluation and treatment.

## Linked entities

- **Diseases:** leukemia (MONDO:0004355), anemia (MONDO:0002280)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** infections (MESH:D007239), atopic disease (MESH:D006969), leukocytosis (MESH:D007964), anemia (MESH:D000740), organomegaly (MESH:D016878), cytopenias (MESH:D006402), Hematogone Hyperplasia (MESH:D006965), Leukemia (MESH:D007938), hypersensitivity reactions (MESH:D006967), Eosinophilia (MESH:D004802), clonal eosinophilia (MESH:C580365), hematological malignancies (MESH:D019337), acute leukemia (MESH:D015470), febrile illness (MESH:D005334), inflammatory disorders (MESH:D007249)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12805969/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12805969/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12805969/full.md

---
Source: https://tomesphere.com/paper/PMC12805969